|
SCAND2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.963410E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.781370E-03 |
| Normal-vs-Stage2 |
2.195600E-01 |
| Normal-vs-Stage3 |
5.861000E-03 |
| Normal-vs-Stage4 |
7.543900E-03 |
| Stage1-vs-Stage2 |
6.329400E-01 |
| Stage1-vs-Stage3 |
3.914600E-01 |
| Stage1-vs-Stage4 |
5.993600E-01 |
| Stage2-vs-Stage3 |
3.676600E-01 |
| Stage2-vs-Stage4 |
3.915000E-01 |
| Stage3-vs-Stage4 |
9.632600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.840030E-03 |
| Normal-vs-AfricanAmerican |
4.682300E-02 |
| Normal-vs-Asian |
9.078300E-03 |
| Caucasian-vs-AfricanAmerican |
4.961000E-01 |
| Caucasian-vs-Asian |
3.681400E-01 |
| AfricanAmerican-vs-Asian |
2.690400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.520910E-03 |
| Normal-vs-Female |
3.336200E-02 |
| Male-vs-Female |
5.702800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.729700E-02 |
| Normal-vs-Extreme_Weight |
1.103260E-03 |
| Normal-vs-Obese |
3.178300E-02 |
| Normal-vs-Extreme_Obese |
3.867900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.408600E-01 |
| Normal_Weight-vs-Obese |
9.327200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.020600E-01 |
| Extreme_Weight-vs-Obese |
3.589400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.785200E-01 |
| Obese-vs-Extreme_Obese |
6.635800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.078350E-03 |
| Normal-vs-Age(41-60Yrs) |
9.092100E-02 |
| Normal-vs-Age(61-80Yrs) |
8.220300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.075870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.718500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.068000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.614600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.662200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.837800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.697760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.976000E-02 |
| Normal-VS-Type2 PRCC |
1.58384999999761E-05 |
| Normal-VS-KIRP CIMP |
1.51275999999978E-05 |
| Normal-VS-Unclassified PRCC |
3.837900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.85880000000061E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.157200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.070600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.619380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.838000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.258300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403900E-03 |
| Normal-vs-N1 |
3.641700E-03 |
| Normal-vs-N2 |
6.004900E-04 |
| N0-vs-N1 |
8.448600E-01 |
| N0-vs-N2 |
1.184210E-01 |
| N1-vs-N2 |
1.769030E-01 |
|
|
